Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: American Urological Association

This article was originally published in The Gray Sheet

Executive Summary

American Urological Association: Releases treatment guidelines for impotence Nov. 4. The guidelines cite vacuum constriction devices, drug injection therapy and penile prosthesis implants as "safe and effective treatment options for men with erectile dysfunction (impotence) caused by physiological reasons," AUA says. Use of venous and arterial surgery for treatment of the condition in those with arteriolosclerotic disease "should be viewed as investigational therapies only and their use should be limited to a research setting," under the guidelines, AUA says...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007048

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel